Skip to main content

Table 3 Reasons for discontinuation of tadalafil OaD treatment by age group

From: Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities

  Number (%) of patients
  Age ≤65 years N = 598 Age >65 years N = 180 Overall N = 778
Discontinued tadalafil OaDa 61 (100.0) 46 (100.0) 107 (100.0)
 Reasons    
  Lack of efficacy (hardness of erection) 17 (27.9) 16 (34.4) 33 (30.8)
  Adverse event 10 (22.5) 12 (26.1) 22 (20.6)
  Cost of medication 11 (18.0) 5 (10.9) 16 (15.0)
  Didn’t want to take a pill every day 7 (11.0) 5 (10.9) 12 (11.2)
  Patient discontinued study 7 (11.5) 2 (4.3) 9 (8.4)
  Partner’s request 2 (3.3) 3 (6.5) 5 (4.7)
  Felt that medication controlled his sexual life 2 (4.2) 1 (2.2) 3 (2.8)
  Slow onset of action 2 (3.3) 1 (2.2) 3 (2.8)
  Lack of efficacy (duration of erection) 1 (1.6) 1 (2.2) 2 (1.9)
  Lack of confidence in medication 1 (1.6) 0 1 (0.9)
  Non-desired spontaneous erections 1 (1.6) 0 1 (0.9)
  1. N number of patients, OaD once a day
  2. aIncludes all patients with documented end date of tadalafil OaD treatment, irrespective if the patient completed or discontinued the study